.svg){kind=small}
.svg){kind=logo}
Randomised Phase III trials with large patient groups
We conduct randomised Phase III trials with large populations and a broad spectrum of therapy areas.
Our model has been crafted to support our sponsors’ needs in the latter stages of drug development.
Examples of Richmond’s accelerated patient recruitment
Number one recruitment site out of 83 centres for a study involving patients with Transthyretin Amyloidosis with Cardiomyopathy. 64 patients were recruited within three months.
Richmond recruited 10% of the total patient volunteers needed for a global heart failure trial in just two months.
We are experts in conducting randomised Phase III clinical trials.
Our specialist clinical team has experience in conducting clinical trials with a broad spectrum of patient groups with common and rare diseases.
Why choose Richmond Pharmacology for Phase III Clinical Trials
Single centre studies
We are equipped to deliver single centre studies for early phase patient trials.
Multi-disciplined teams
We have access to specialist consultants, professors and medical practitioners through our academic and medical partnerships.
Hospital-style setting
.svg)
Our multi-disciplinary team operate in a hospital-style setting which facilitates efficient, safe trial management.
Hear from our sponsors
.svg){kind=small}
-min.jpg)
.jpg)
Latest news
Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects
Richmond Pharmacology becomes Richmond in Brand Refresh
Events
The 44th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)
